NEW YORK (AP) — Federal health advisers are meeting to issue recommendations on how to vaccinate kids as young as 12 with the Pfizer COVID-19 vaccine.
This week, the Food and Drug Administration cleared the expanded use of Pfizer’s shots, citing evidence the shots worked as well in those 12 to 15 years old as those 16 and older. Kids in some places are already rolling up their sleeves.
But much of the nation is waiting for Wednesday’s recommendations from advisers to the Centers for Disease Control and Prevention. Many states will be shipping doses to pediatricians and even to schools.
Pfizer is not the only company seeking to lower the age limit for its vaccine. Moderna recently said preliminary results from its study in 12- to 17-year-olds show strong protection and no serious side effects, data the FDA will need to scrutinize.